I hope youre right Pete, but IMO that is a steep climb. I think we continue to fight and claw to get into the 2s again, and by august we may have 1 or 2 'events' that cause a gap up like we recently saw with ACAD, or like with DNDN in the past. We may close at 2.80 one day, and wake up the next morning to 8 per share. But still, 20 would be amazing, time will tell. Most important of all is the trials are proceeding smoothly, the numbers will follow and sort themselves out following the lead of the science.